Skip to main content
Caplight Logo









Umbria Bioengineering Technologies

Umbria Bioengineering Technologies

Private
AssisiHealthcare & Life Scienceshttps://www.ubt-tech.com/

Last Round

Grant

Nov 28, 2022

Total Funding Raised

$3.97M

Company Overview

Umbria Bioengineering Technologies is a biomedical company that develops and commercializes innovative medical imaging devices based on microwave technology as a safe, non-ionizing alternative to X-rays.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

microwave imagingmedical imagingbreast cancer screeningnon-ionizing radiationmedical devicediagnostic imagingradiation-free imagingAI medical imagingclinical decision supportstroke detectionlung lesion detectionradiology alternativemedtechelectromagnetic compatibilityEMC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Umbria Bioengineering Technologies Comparables

Compare Umbria Bioengineering Technologies with similar companies based on industry and business-model similarity.

Umbria Bioengineering Technologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MIMA Technologies P.C.
89%
Micrima Ltd.
85%
Microwave Vision Group
83%

Umbria Bioengineering Technologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 28, 2022
GrantOct 1, 2018
GrantAug 1, 2017

Key People

Founding team and executive leadership

Sabatino Tiberi

CEO

Executive Team

Umbria Bioengineering Technologies Investors

Notable investors and investment history

Umbria Bioengineering Technologies investors
InvestorRounds
UKRI Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors increased 107% MoM.

  • Jan 20, 2026

    Monthly visitors increased 38% MoM.

Umbria Bioengineering Technologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Umbria Bioengineering Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Umbria Bioengineering Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersAssisi
Employee Range17
Year Founded2015
Last FundingNov 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?